Table 3.
ONTOLOGY | ID | Description | GeneRatio | BgRatio | p-value | p.adjust | qvalue |
---|---|---|---|---|---|---|---|
BP | GO:0006885 | regulation of pH | 7/101 | 98/18,670 | 1.02e-06 | 0.001 | 0.001 |
BP | GO:0006953 | acute-phase response | 5/101 | 47/18,670 | 5.37e-06 | 0.003 | 0.003 |
BP | GO:0051453 | regulation of intracellular pH | 6/101 | 84/18,670 | 6.24e-06 | 0.003 | 0.003 |
BP | GO:0030641 | regulation of cellular pH | 6/101 | 90/18,670 | 9.31e-06 | 0.003 | 0.003 |
BP | GO:0055067 | monovalent inorganic cation homeostasis | 7/101 | 154/18,670 | 2.04e-05 | 0.005 | 0.005 |
CC | GO:0016323 | basolateral plasma membrane | 8/108 | 217/19,717 | 2.59e-05 | 0.004 | 0.004 |
CC | GO:0016471 | vacuolar proton-transporting V-type ATPase complex | 3/108 | 17/19,717 | 1.03e-04 | 0.008 | 0.007 |
CC | GO:0033176 | proton-transporting V-type ATPase complex | 3/108 | 26/19,717 | 3.79e-04 | 0.015 | 0.014 |
CC | GO:0034364 | high-density lipoprotein particle | 3/108 | 26/19,717 | 3.79e-04 | 0.015 | 0.014 |
CC | GO:0015030 | Cajal body | 4/108 | 77/19,717 | 8.47e-04 | 0.023 | 0.021 |
MF | GO:0099516 | ion antiporter activity | 5/85 | 58/17,697 | 8.51e-06 | 0.002 | 0.002 |
MF | GO:0015297 | antiporter activity | 5/85 | 85/17,697 | 5.51e-05 | 0.005 | 0.003 |
MF | GO:0022821 | potassium ion antiporter activity | 3/85 | 16/17697 | 5.72e-05 | 0.005 | 0.003 |
MF | GO:0030506 | ankyrin binding | 3/85 | 20/17,697 | 1.15e-04 | 0.007 | 0.005 |
MF | GO:0015491 | cation:cation antiporter activity | 3/85 | 26/17,697 | 2.57e-04 | 0.011 | 0.009 |
KEGG | hsa04966 | Collecting duct acid secretion | 5/39 | 27/8,076 | 1.50e-07 | 2.00e-05 | 1.81e-05 |
KEGG | hsa04721 | Synaptic vesicle cycle | 4/39 | 78/8,076 | 5.12e-04 | 0.034 | 0.031 |
KEGG | hsa05323 | Rheumatoid arthritis | 4/39 | 93/8,076 | 9.96e-04 | 0.044 | 0.040 |
KEGG | hsa05110 | Vibrio cholerae infection | 3/39 | 50/8,076 | 0.002 | 0.058 | 0.052 |